November 18–19, 2026 | Burlingame, CA | Booth [XX]
Mednet is heading to the Bay Area for the COG: Small and Mid BioPharma Summit, bringing together clinical leaders from emerging and mid-sized biotech and biopharma companies to share ideas for running smarter, more efficient clinical trials.
Visit Booth 28 to meet Stacey Lasser, Scott Robertson, and Griffin Robertson and learn how Mednet and CRScube are expanding the technology available to clinical teams, with new capabilities designed to reduce manual work, improve data quality, and help studies move faster.
See what’s next for clinical trial execution
From building an EDC database to capturing and cleaning clinical data, traditional trial processes still rely on a significant amount of manual work. New advances in AI and automation are creating opportunities to address those inefficiencies earlier, while keeping experienced clinical professionals in control.
Join us on November 18 at 10:15 a.m. for:
From Protocol to EDC and Beyond: How AI Is Rewriting Clinical Trial Execution
Presented by Stacey Lasser
Clinical trials still rely on manual processes that consume time and resources, from study build and data capture to downstream review and cleanup.
This session will explore how AI and automation are beginning to change that model by addressing inefficiencies earlier and improving data quality at the source. Stacey will discuss what this evolution means for clinical teams and the future of trial execution, including how technology can reduce repetitive work while enabling experienced professionals to focus on higher-value oversight, insights, and decision-making.
COG: Small and Mid BioPharma Summit
November 18–19, 2026
Hyatt Regency San Francisco Airport
Burlingame, California